Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurology | 5 | 2025 | 117 | 2.520 |
Why?
|
| Clinical Clerkship | 3 | 2025 | 70 | 1.180 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2025 | 170 | 1.060 |
Why?
|
| Competency-Based Education | 1 | 2025 | 81 | 0.880 |
Why?
|
| Workplace | 1 | 2025 | 83 | 0.870 |
Why?
|
| Students, Medical | 4 | 2024 | 343 | 0.860 |
Why?
|
| Post-Traumatic Headache | 1 | 2024 | 6 | 0.820 |
Why?
|
| Educational Measurement | 1 | 2025 | 317 | 0.770 |
Why?
|
| Migraine Disorders | 1 | 2022 | 61 | 0.710 |
Why?
|
| Outpatients | 1 | 2022 | 266 | 0.650 |
Why?
|
| Clinical Competence | 1 | 2025 | 1055 | 0.560 |
Why?
|
| Faculty, Medical | 2 | 2024 | 279 | 0.340 |
Why?
|
| Limbic Encephalitis | 1 | 2011 | 2 | 0.340 |
Why?
|
| Immune Reconstitution Inflammatory Syndrome | 1 | 2011 | 18 | 0.330 |
Why?
|
| Toxoplasmosis | 1 | 2011 | 22 | 0.330 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2011 | 137 | 0.310 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 127 | 0.310 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2011 | 218 | 0.300 |
Why?
|
| Immunologic Factors | 1 | 2011 | 187 | 0.300 |
Why?
|
| Autoantibodies | 1 | 2011 | 439 | 0.270 |
Why?
|
| Academic Success | 1 | 2024 | 22 | 0.210 |
Why?
|
| Neck Pain | 1 | 2024 | 20 | 0.210 |
Why?
|
| Lactation | 1 | 2024 | 197 | 0.200 |
Why?
|
| Headache | 1 | 2024 | 109 | 0.190 |
Why?
|
| Mental Disorders | 1 | 2011 | 896 | 0.190 |
Why?
|
| Cervical Vertebrae | 1 | 2024 | 118 | 0.190 |
Why?
|
| Breast Feeding | 1 | 2024 | 229 | 0.190 |
Why?
|
| Problem-Based Learning | 1 | 2023 | 80 | 0.180 |
Why?
|
| Leadership | 1 | 2024 | 244 | 0.180 |
Why?
|
| Interprofessional Relations | 1 | 2023 | 149 | 0.180 |
Why?
|
| Humans | 15 | 2025 | 130854 | 0.160 |
Why?
|
| Pathology | 1 | 2020 | 27 | 0.160 |
Why?
|
| Education, Medical | 1 | 2024 | 293 | 0.160 |
Why?
|
| Laboratories | 1 | 2020 | 79 | 0.150 |
Why?
|
| Education, Distance | 1 | 2020 | 69 | 0.150 |
Why?
|
| Curriculum | 2 | 2020 | 785 | 0.130 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2013 | 132 | 0.090 |
Why?
|
| Walking | 1 | 2013 | 213 | 0.090 |
Why?
|
| Epilepsy, Reflex | 1 | 2010 | 5 | 0.080 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 60 | 0.080 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2010 | 44 | 0.080 |
Why?
|
| Benzodiazepines | 1 | 2011 | 104 | 0.080 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2011 | 146 | 0.080 |
Why?
|
| Rituximab | 1 | 2011 | 170 | 0.080 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2011 | 257 | 0.070 |
Why?
|
| Adult | 6 | 2024 | 31238 | 0.070 |
Why?
|
| Eating | 1 | 2010 | 377 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 451 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 364 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 4017 | 0.060 |
Why?
|
| Seizures | 1 | 2010 | 876 | 0.060 |
Why?
|
| Professional Misconduct | 1 | 2024 | 34 | 0.050 |
Why?
|
| Awards and Prizes | 1 | 2024 | 62 | 0.050 |
Why?
|
| Perception | 1 | 2024 | 231 | 0.050 |
Why?
|
| Faculty | 1 | 2024 | 96 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 318 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5199 | 0.040 |
Why?
|
| Epilepsy | 1 | 2009 | 872 | 0.040 |
Why?
|
| Male | 5 | 2024 | 64763 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 1350 | 0.040 |
Why?
|
| Learning | 1 | 2024 | 370 | 0.040 |
Why?
|
| Sex Factors | 1 | 2024 | 1342 | 0.040 |
Why?
|
| Clinical Laboratory Services | 1 | 2020 | 19 | 0.040 |
Why?
|
| Formative Feedback | 1 | 2020 | 33 | 0.040 |
Why?
|
| Cost Savings | 1 | 2020 | 79 | 0.040 |
Why?
|
| Physician Executives | 1 | 2020 | 33 | 0.040 |
Why?
|
| Young Adult | 2 | 2011 | 10040 | 0.040 |
Why?
|
| Middle Aged | 4 | 2024 | 28511 | 0.040 |
Why?
|
| United States | 2 | 2024 | 11865 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 442 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 12913 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 548 | 0.030 |
Why?
|
| Health Care Costs | 1 | 2020 | 403 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1457 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3807 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2010 | 858 | 0.030 |
Why?
|
| Female | 5 | 2024 | 70550 | 0.030 |
Why?
|
| Postural Balance | 1 | 2013 | 102 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 270 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 607 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2010 | 136 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1216 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 269 | 0.020 |
Why?
|
| Self Concept | 1 | 2009 | 158 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 3827 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2010 | 360 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 233 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 3393 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 1215 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1892 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 808 | 0.010 |
Why?
|
| Depression | 1 | 2009 | 1321 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 20970 | 0.010 |
Why?
|